subject area of
- A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes Academic Article
- Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications Academic Article
- Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease Academic Article
- BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase Academic Article
- Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT) Academic Article
- Clopidogrel in acute coronary syndromes: Where are we now? Academic Article
- Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Academic Article
- Complete Revascularization with Multivessel PCI for Myocardial Infarction Academic Article
-
Contemporary use of
guideline‐based higher potencyP2Y12 receptor inhibitor therapy in patients withmoderate‐to‐high risknon‐ST‐segment elevation myocardial infarction: Results from the CanadianACS reflectiveII cross‐sectional study Academic Article - Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention Academic Article
- Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI Academic Article
- Evidence that 5-HT stimulates intracellular Ca2+signalling and activates pannexin-1 currents in type II cells of the rat carotid body Academic Article
- Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes Academic Article
- Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention Academic Article
- Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy Academic Article
- New antithrombotic agents—insights from clinical trials Academic Article
- Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial Academic Article
- P2Y12 receptor inhibitor resistance and coronary artery disease Academic Article
- Platelet Transfusion for Ticagrelor Reversal Academic Article
- Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation Academic Article
- Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD) Academic Article
- Reply to ‘Concerns about 2015 ERC Guidelines on pre-hospital use of ADP-receptor antagonists in patients with STEMI (ACS 335)’ Academic Article
- Role of phenotypic and genetic testing in managing clopidogrel therapy Academic Article
- Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis Academic Article